Radiobiological Modelling of the Therapeutic Ratio for the Addition of Synchronous Chemotherapy to Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Clinical Oncology

Volumn 22, Issue 2, 2010, Pages 125-130

  Hartley, A ^a   Sanghera, P ^a   Glaholm, J ^a   Mehanna, H ^b,c   McConkey, C ^d   Fowler, J ^e  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Chemoradiation; head and neck cancer; radiobiological modelling; squamous cell carcinoma; therapeutic ratio

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; MODELS, BIOLOGICAL; MUCOSITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 75249091436     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.10.004     Document Type: Article

References (26)

1. Matzinger O., Zouhair A., Mirimanoff R., and Ozsahin M. Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck. Clin Oncol 21 (2009) 525-531
2. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
3. Kasibhatla M., Kirkpatrick J., and Brizel D. How much radiation is the chemotherapy worth in advanced head and neck cancer?. Int J Radiat Oncol Biol Phys 68 (2007) 1491-1495
4. Lee I., and Eisbruch A. Mucositis versus tumor control: the therapeutic index of adding chemotherapy to irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 75 (2009) 1060-1063
5. Fowler J. Correction to Kasibhatla et al. How much radiation is the chemotherapy worth in advanced head and neck cancer?. Int J Radiat Oncol Biol Phys 68 (2007) 1491-1495
6. Int J Radiat Oncol Biol Phys 71 (2008) 326-329
7. Hartley A., Sanghera P., Glaholm J., et al. Modelling the contribution of synchronous chemotherapy to the rate of grade 3 and 4 mucositis in locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 75 (2009) 315
8. Fowler J.F., Harari P.M., Leborgne F., et al. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules. Radiother Oncol 69 (2003) 161-168
9. Fu K., Pajak T., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
10. Overgaard J., Hansen H., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. Lancet 362 (2003) 933-940
11. Poulsen M.G., Denham J.W., Peters L.J., et al. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study. Radiother Oncol 60 (2001) 113
12. Bentzen S., Saunders M., Dische S., et al. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 60 (2001) 123-135
13. Dische S., Saunders M., Barrett A., et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44 (1997) 123-136
14. Horiot J.C., Le Fur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25 (1992) 231-241
15. Bourrhis J., Lapeyre M., Tortochaux J., et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: A GORTEC Trial. J Clin Oncol 24 (2006) 2873-2878
16. Bourrhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 9538 (2006) 843-854
17. Browman G.P., Cripps C., Hodson D.I., et al. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 12 (1994) 2648-2653
18. Haffty B.G., Son Y.H., Papac R., et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. J Clin Oncol 15 (1997) 268-276
19. Adelstein D.J., Lavertu P., Saxton J.P., et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88 (2000) 876-883
20. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
21. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
22. Olmi P., Crispino S., Fallai C., et al. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy-a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 78-92
23. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
24. Geh J.I., Bond S.J., and Bentzen S.M. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 78 (2006) 236-244
25. Jones B., and Sanghera P. Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma. Int J Radiat Oncol Biol Phys 68 (2007) 441-448
26. Plataniotis G., and Dale R. Use of concept of chemotherapy-equivalent biologically effective dose to provide quantitative evaluation of contribution of chemotherapy to local tumour control in chemoradiotherapy cervical cancer trials. Int J Radiat Oncol Biol Phys 72 (2007) 1538-1543